192 related articles for article (PubMed ID: 8668543)
1. Transcriptional activation by Oct-3: evidence for a specific role of the POU-specific domain in mediating functional interaction with Oct-1.
Vigano MA; Staudt LM
Nucleic Acids Res; 1996 Jun; 24(11):2112-8. PubMed ID: 8668543
[TBL] [Abstract][Full Text] [Related]
2. Repression of Ets-2-induced transactivation of the tau interferon promoter by Oct-4.
Ezashi T; Ghosh D; Roberts RM
Mol Cell Biol; 2001 Dec; 21(23):7883-91. PubMed ID: 11689681
[TBL] [Abstract][Full Text] [Related]
3. The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain.
Brehm A; Ohbo K; Schöler H
Mol Cell Biol; 1997 Jan; 17(1):154-62. PubMed ID: 8972195
[TBL] [Abstract][Full Text] [Related]
4. High mobility group I/Y protein functions as a specific cofactor for Oct-2A: mapping of interaction domains.
Abdulkadir SA; Casolaro V; Tai AK; Thanos D; Ono SJ
J Leukoc Biol; 1998 Nov; 64(5):681-91. PubMed ID: 9823775
[TBL] [Abstract][Full Text] [Related]
5. OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain.
Babb R; Cleary MA; Herr W
Mol Cell Biol; 1997 Dec; 17(12):7295-305. PubMed ID: 9372961
[TBL] [Abstract][Full Text] [Related]
6. Segments of the POU domain influence one another's DNA-binding specificity.
Aurora R; Herr W
Mol Cell Biol; 1992 Feb; 12(2):455-67. PubMed ID: 1732727
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor interactions with Oct-1 and Brn-1 are physically and functionally distinct.
González MI; Tovaglieri A; Robins DM
Mol Cell Endocrinol; 2002 Apr; 190(1-2):39-49. PubMed ID: 11997177
[TBL] [Abstract][Full Text] [Related]
8. POU domain factors in neural development.
Schonemann MD; Ryan AK; Erkman L; McEvilly RJ; Bermingham J; Rosenfeld MG
Adv Exp Med Biol; 1998; 449():39-53. PubMed ID: 10026784
[TBL] [Abstract][Full Text] [Related]
9. Sequential expression of multiple POU proteins during amphibian early development.
Hinkley CS; Martin JF; Leibham D; Perry M
Mol Cell Biol; 1992 Feb; 12(2):638-49. PubMed ID: 1732736
[TBL] [Abstract][Full Text] [Related]
10. The Oct-2 glutamine-rich and proline-rich activation domains can synergize with each other or duplicates of themselves to activate transcription.
Tanaka M; Clouston WM; Herr W
Mol Cell Biol; 1994 Sep; 14(9):6046-55. PubMed ID: 8065338
[TBL] [Abstract][Full Text] [Related]
11. Differential in vivo activation of the class II and class III snRNA genes by the POU-specific domain of Oct-1.
Murphy S
Nucleic Acids Res; 1997 Jun; 25(11):2068-76. PubMed ID: 9153304
[TBL] [Abstract][Full Text] [Related]
12. The Oct-1 POU-specific domain can stimulate small nuclear RNA gene transcription by stabilizing the basal transcription complex SNAPc.
Mittal V; Cleary MA; Herr W; Hernandez N
Mol Cell Biol; 1996 May; 16(5):1955-65. PubMed ID: 8628262
[TBL] [Abstract][Full Text] [Related]
13. The Oct-1 POU domain activates snRNA gene transcription by contacting a region in the SNAPc largest subunit that bears sequence similarities to the Oct-1 coactivator OBF-1.
Ford E; Strubin M; Hernandez N
Genes Dev; 1998 Nov; 12(22):3528-40. PubMed ID: 9832505
[TBL] [Abstract][Full Text] [Related]
14. Activator recruitment by the general transcription machinery: X-ray structural analysis of the Oct-1 POU domain/human U1 octamer/SNAP190 peptide ternary complex.
Hovde S; Hinkley CS; Strong K; Brooks A; Gu L; Henry RW; Geiger J
Genes Dev; 2002 Nov; 16(21):2772-7. PubMed ID: 12414730
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain.
Sturm RA; Das G; Herr W
Genes Dev; 1988 Dec; 2(12A):1582-99. PubMed ID: 2905684
[TBL] [Abstract][Full Text] [Related]
16. Silencing mediator for retinoid and thyroid hormone receptors interacts with octamer transcription factor-1 and acts as a transcriptional repressor.
Kakizawa T; Miyamoto T; Ichikawa K; Takeda T; Suzuki S; Mori J; Kumagai M; Yamashita K; Hashizume K
J Biol Chem; 2001 Mar; 276(13):9720-5. PubMed ID: 11134019
[TBL] [Abstract][Full Text] [Related]
17. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W
EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375
[TBL] [Abstract][Full Text] [Related]
18. Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter.
Préfontaine GG; Walther R; Giffin W; Lemieux ME; Pope L; Haché RJ
J Biol Chem; 1999 Sep; 274(38):26713-9. PubMed ID: 10480874
[TBL] [Abstract][Full Text] [Related]
19. New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2.
Botquin V; Hess H; Fuhrmann G; Anastassiadis C; Gross MK; Vriend G; Schöler HR
Genes Dev; 1998 Jul; 12(13):2073-90. PubMed ID: 9649510
[TBL] [Abstract][Full Text] [Related]
20. Characterization of chicken octamer-binding proteins demonstrates that POU domain-containing homeobox transcription factors have been highly conserved during vertebrate evolution.
Petryniak B; Staudt LM; Postema CE; McCormack WT; Thompson CB
Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1099-103. PubMed ID: 1967834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
